Thyroid dysfunction in human immuno-deficiency virus infected patients: a non-randomized, cross-sectional, single-center study

Vaheed U. Mujawar; Anilkumar C. Byakod; Lakshmi Devi P. P.; Basavaraj N. Walikar; Tai A. Usmangani

doi:10.18203/2320-6012.ijrms20230590

Authors

Vaheed U. Mujawar Department of General Medicine, Al Ameen Medical College Hospital, Vijayapur, Karnataka, India
Anilkumar C. Byakod Department of General Medicine, Al Ameen Medical College Hospital, Vijayapur, Karnataka, India
Lakshmi Devi P. P. Department of ENT, Al Ameen Medical College Hospital, Vijayapur, Karnataka, India
Basavaraj N. Walikar Department of ENT, Al Ameen Medical College Hospital, Vijayapur, Karnataka, India
Tai A. Usmangani Department of ENT, Al Ameen Medical College Hospital, Vijayapur, Karnataka, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20230590

Keywords:

Thyroid dysfunction, HIV, India, Sub clinical hypothyroidism

Abstract

Background: Increasing prevalence of thyroid dysfunction has been reported in human immuno-deficiency virus (HIV)-infected patients. However, there is insufficient evidence to recommend routine thyroid screening of asymptomatic individuals. Hence, this study was undertaken in an attempt to resolve these issues. Objectives of this non-randomized, cross-sectional, single-center study was to study thyroid function in HIV positive patients at various stages of disease.

Methods: This single-center study was carried out at Al-Ameen Medical College Hospital and Government District Hospital Bijapur, Karnataka, India from December 2020 to December 2022. The final selected study population included newly diagnosed adult and adolescent (17-60 years) HIV+ patients was composed of 100 participants of either gender. Patients were interviewed and enrolled in the study after examining in detail according to the proforma and then by taking their written consent and explaining the purpose of the study. The thyroid hormone assays (S. TSH, FT3 and FT4) were done by chemiluminescence immuno assay (CLIA) using ADVIA Centaur-equipment.

Results: Overall mean age was 36 years (range in years: 17–66 years) and 66 patients (66%) were males. Male: female ratio of 1.94:1 was recorded. In the 50 patients having acquired immuno-deficiency virus (AIDS), FT3 levels ranged from 0.230 to 4.0 picogram/ml with a mean of 2.131+0.9826 picogram/ml. In 50 patients having AIDS, the FT4 levels ranged from 0.30 to 1.90 nanogram/dI with a mean 1.179±0.4484 nanogram/dl.

Conclusions: All forms of thyroid dysfunction were observed.

Metrics

Metrics Loading ...

References

Micali C, Russotto Y, Celesia BM, Santoro L, Marino A, Pellicanò GF, Nunnari G, VenanziRullo E. Thyroid diseases and thyroid asymptomatic dysfunction in people living with HIV. Infect Dis Rep. 2022;14(5):655-67.

Himanshu D, Tandon R, Kumar S, Sawlani KK, Verma SK, MisraR, Atam V. Is International HIV Dementia Scale good enough to diagnose HIV-associated neurocognitive disorders? J Fam Med Prim Care. 2022;11(9):5060-4.

Sethi Y, Uniyal N, Maheshwari S, Sinha R, Goel A. Thyroid Function Abnormalities in the Acute Phase of COVID-19: A Cross-Sectional Hospital-Based Study From North India. Cureus. 2022;14(5).

Sah UK, Ansari M, Sah AK, Chaudhary P, Gupta S, Kumar P, Sah JP. Study of thyroid dysfunction in people living with HIV in Nepalese population undergoing antiretroviral therapy: a cross-sectional study. Int J STD AIDS. 2023;09564624221147963.

Kornete L, Terauda R, Sausa S, Dzivite-Krisane I, Melderis I, Sitkare V, et al. Graves’ disease as a manifestation of immune reconstitution inflammatory syndrome in an HIV-1-infected adolescent patient: A case report. J Clin Transl Endocrinol. 2022;100118.

Raguthu CC, Gajjela H, Kela I, Kakarala CL, Hassan M, Belavadi R, et al. Cardiovascular Involvement in Thyrotoxicosis Resulting in Heart Failure: The Risk Factors and Hemodynamic Implications. Cureus. 2022;14(1).

Deb N, Roy P. Human immunodeficiency virus-associated nephropathy with hypothyroidism. Apollo Med. 2022;19(4):282.

Razvi S, Bhana S, Mrabeti S. Challenges in interpreting thyroid stimulating hormone results in the diagnosis of thyroid dysfunction. J Thyroid Res. 2019;4106816.

Saidi S, Jaafar SN, Daud A, Musa R, Ahmad NN. Relationship between levels of thyroid stimulating hormone, age, and gender, with symptoms of depression among patients with thyroid disorders as measured by the Depression Anxiety Stress Scale 21 (DASS-21). Enfermeriaclinica. 2018;28:180-3.

Hennessey JV, Garber JR, Woeber KA, Cobin R, Klein I, Thyroid Scientific Committee. American association of clinical endocrinologists and American college of endocrinology position statement on thyroid dysfunction case finding. Endocrine Practice. 2016;22(2):262-70.

Turk MC, Bakker CJ, Spencer SM, Lofgren SM. Systematic review of sex differences in the relationship between hormones and depression in HIV. Psychoneuroendocrinology. 2022;105665.

Ayeni OA, O'Neil DS, Pumpalova YS, Chen WC, Nietz S, Phakathi B, et al. Impact of HIV infection on survival among women with stage I-III breast cancer: Results from the South African breast cancer and HIV outcomes study. Int J Cancer. 2022;151(2):209-21.

Kaneria MV, Kahalekar VV. A study of thyroid dysfunction in HIV infected patients in a tertiary care hospital. Int J Adv Med. 2016;3(3):708-15.

Verma RK, Giri R, Gupta C, Srivastava V. Study of thyroid profile in seropositive HIV adults patients on HAART regimen. Int J Adv Med. 2017;4(4):1092.

Sharma N, Sharma LK, Dutta D, Gadpayle AK, Anand A, Gaurav K, et al. Prevalence and predictors of thyroid dysfunction in patients with HIV infection and acquired immunodeficiency syndrome: An Indian perspective. J Thyroid Res. 2015;517173.

Roszkiewicz J, Smolewska E. Kaleidoscope of autoimmune diseases in HIV infection. Rheumatol Int. 2016;36(11):1481-91.

Dev N, Sahoo R, Kulshreshtha B, Gadpayle AK, Sharma SC. Prevalence of thyroid dysfunction and its correlation with CD4 count in newly-diagnosed HIV-positive adults–a cross-sectional study. Int J STD AIDS. 2015;26(13):965-70.

Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus—infected patients: A need for screening. Clin Infect Dis. 2020;37(4):579-83.

Raffi F, Brisseau JM, Planchon B, Rémi JP, Barrier JH, Grolleau JY. Endocrine function in 98 HIV-infected patients: a prospective study. AIDS (London, England). 2019;5(6):729-33.

Quirino T, Bongiovanni M, Ricci E, Chebat E, Carradori S, Martinelli C, et al. Hypothyroidism in HIV-infected patients who have or have not received HAART. Clin Infect Dis. 2019;38(4):596-7.

Madge S, Smith CJ, Lampe FC, Thomas M, Johnson MA, Youle M, et al. No association between HIV disease and its treatment and thyroid function. HIV Med. 2007;8(1):22-7.